Literature DB >> 22492993

C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans.

Ayo P Doumatey1, Guanjie Chen, Fasil Tekola Ayele, Jie Zhou, Michael Erdos, Daniel Shriner, Hanxia Huang, Jokotade Adeleye, Williams Balogun, Olufemi Fasanmade, Thomas Johnson, Johnnie Oli, Godfrey Okafor, Albert Amoah, Benjamin A Eghan, Kofi Agyenim-Boateng, Joseph Acheampong, Clement Adebamowo, Norman P Gerry, Michael F Christman, Adebowale Adeyemo, Charles N Rotimi.   

Abstract

C-reactive protein (CRP) is an acute phase reactant protein produced primarily by the liver. Circulating CRP levels are influenced by genetic and non-genetic factors, including infection and obesity. Genome-wide association studies (GWAS) provide an unbiased approach towards identifying loci influencing CRP levels. None of the six GWAS for CRP levels has been conducted in an African ancestry population. The present study aims to: (i) identify genetic variants that influence serum CRP in African Americans (AA) using a genome-wide association approach and replicate these findings in West Africans (WA), (ii) assess transferability of major signals for CRP reported in European ancestry populations (EA) to AA and (iii) use the weak linkage disequilibrium (LD) structure characteristic of African ancestry populations to fine-map the previously reported CRP locus. The discovery cohort comprised 837 unrelated AA, with the replication of significant single-nucleotide polymorphisms (SNPs) assessed in 486 WA. The association analysis was conducted with 2 366 856 genotyped and imputed SNPs under an additive genetic model with adjustment for appropriate covariates. Genome-wide and replication significances were set at P < 5 × 10(-8) and P < 0.05, respectively. Ten SNPs in (CRP pseudogene-1) CRPP1 and CRP genes were associated with serum CRP (P = 2.4 × 10(-09) to 4.3 × 10(-11)). All but one of the top-scoring SNPs associated with CRP in AA were successfully replicated in WA. CRP signals previously identified in EA samples were transferable to AAs, and we were able to fine-map this signal, reducing the region of interest from the 25 kb of LD around the locus in the HapMap CEU sample to only 8 kb in our AA sample.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492993      PMCID: PMC3373247          DOI: 10.1093/hmg/dds133

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

Review 2.  The C-reactive protein.

Authors:  B Clyne; J S Olshaker
Journal:  J Emerg Med       Date:  1999 Nov-Dec       Impact factor: 1.484

3.  Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines.

Authors:  M K Ganapathi; L T May; D Schultz; A Brabenec; J Weinstein; P B Sehgal; I Kushner
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

Review 4.  High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease.

Authors:  Edward T H Yeh
Journal:  Clin Cardiol       Date:  2005-09       Impact factor: 2.882

5.  In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study.

Authors:  C N Rotimi; G M Dunston; K Berg; O Akinsete; A Amoah; S Owusu; J Acheampong; K Boateng; J Oli; G Okafor; B Onyenekwe; B Osotimehin; F Abbiyesuku; T Johnson; O Fasanmade; P Furbert-Harris; R Kittles; M Vekich; O Adegoke; G Bonney; F Collins
Journal:  Ann Epidemiol       Date:  2001-01       Impact factor: 3.797

6.  Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes.

Authors:  J V Castell; M J Gómez-Lechón; M David; T Andus; T Geiger; R Trullenque; R Fabra; P C Heinrich
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

7.  Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene.

Authors:  B Weinhold; U Rüther
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

8.  Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.

Authors:  Christopher S Carlson; Shelley Force Aldred; Philip K Lee; Russell P Tracy; Stephen M Schwartz; Mark Rieder; Kiang Liu; O Dale Williams; Carlos Iribarren; E Cora Lewis; Myriam Fornage; Eric Boerwinkle; Myron Gross; Cashell Jaquish; Deborah A Nickerson; Richard M Myers; David S Siscovick; Alexander P Reiner
Journal:  Am J Hum Genet       Date:  2005-05-16       Impact factor: 11.025

9.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

10.  A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America Diabetes Mellitus (AADM) Study.

Authors:  Charles N Rotimi; Guanjie Chen; Adebowale A Adeyemo; Paulette Furbert-Harris; Debra Parish-Gause; Jie Zhou; Kate Berg; Olufemi Adegoke; Albert Amoah; Samuel Owusu; Joseph Acheampong; Kofi Agyenim-Boateng; Benjamin A Eghan; Johnnie Oli; Godfrey Okafor; Ester Ofoegbu; Babatunde Osotimehin; Fayeofori Abbiyesuku; Thomas Johnson; Theresa Rufus; Olufemi Fasanmade; Rick Kittles; Harold Daniel; Yuanxiu Chen; Georgia Dunston; Francis S Collins; Debra Guass
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  21 in total

1.  Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease.

Authors:  Jae-Jung Kim; Sin Weon Yun; Jeong Jin Yu; Kyung Lim Yoon; Kyung-Yil Lee; Hong-Ryang Kil; Gi Beom Kim; Myung Ki Han; Min Seob Song; Hyoung Doo Lee; Jung Hye Byeon; Saejung Sohn; Young Mi Hong; Gi Young Jang; Jong-Keuk Lee
Journal:  Pediatr Cardiol       Date:  2014-09-30       Impact factor: 1.655

2.  Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium.

Authors:  Elizabeth O Ofili; Alecia Fair; Keith Norris; Joseph G Verbalis; Russell Poland; Gordon Bernard; David S Stephens; Steven M Dubinett; Julianne Imperato-McGinley; Robert P Dottin; Jill Pulley; Andrew West; Arleen Brown; Thomas A Mellman
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

Review 3.  The genomic landscape of African populations in health and disease.

Authors:  Charles N Rotimi; Amy R Bentley; Ayo P Doumatey; Guanjie Chen; Daniel Shriner; Adebowale Adeyemo
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

4.  Association of exome sequences with plasma C-reactive protein levels in >9000 participants.

Authors:  Ursula M Schick; Paul L Auer; Joshua C Bis; Honghuang Lin; Peng Wei; Nathan Pankratz; Leslie A Lange; Jennifer Brody; Nathan O Stitziel; Daniel S Kim; Christopher S Carlson; Myriam Fornage; Jeffery Haessler; Li Hsu; Rebecca D Jackson; Charles Kooperberg; Suzanne M Leal; Bruce M Psaty; Eric Boerwinkle; Russell Tracy; Diego Ardissino; Svati Shah; Cristen Willer; Ruth Loos; Olle Melander; Ruth Mcpherson; Kees Hovingh; Muredach Reilly; Hugh Watkins; Domenico Girelli; Pierre Fontanillas; Daniel I Chasman; Stacey B Gabriel; Richard Gibbs; Deborah A Nickerson; Sekar Kathiresan; Ulrike Peters; Josée Dupuis; James G Wilson; Stephen S Rich; Alanna C Morrison; Emelia J Benjamin; Myron D Gross; Alex P Reiner
Journal:  Hum Mol Genet       Date:  2014-09-03       Impact factor: 6.150

5.  Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women.

Authors:  Alex P Reiner; Sandra Beleza; Nora Franceschini; Paul L Auer; Jennifer G Robinson; Charles Kooperberg; Ulrike Peters; Hua Tang
Journal:  Am J Hum Genet       Date:  2012-08-30       Impact factor: 11.025

6.  Discovery, fine-mapping, and conditional analyses of genetic variants associated with C-reactive protein in multiethnic populations using the Metabochip in the Population Architecture using Genomics and Epidemiology (PAGE) study.

Authors:  Jonathan M Kocarnik; Melissa Richard; Misa Graff; Jeffrey Haessler; Stephanie Bien; Chris Carlson; Cara L Carty; Alexander P Reiner; Christy L Avery; Christie M Ballantyne; Andrea Z LaCroix; Themistocles L Assimes; Maja Barbalic; Nathan Pankratz; Weihong Tang; Ran Tao; Dongquan Chen; Gregory A Talavera; Martha L Daviglus; Diana A Chirinos-Medina; Rocio Pereira; Katie Nishimura; Petra Bužková; Lyle G Best; José Luis Ambite; Iona Cheng; Dana C Crawford; Lucia A Hindorff; Myriam Fornage; Gerardo Heiss; Kari E North; Christopher A Haiman; Ulrike Peters; Loic Le Marchand; Charles Kooperberg
Journal:  Hum Mol Genet       Date:  2018-08-15       Impact factor: 6.150

Review 7.  Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.

Authors:  Emmanuel Peprah; Huichun Xu; Fasil Tekola-Ayele; Charmaine D Royal
Journal:  Public Health Genomics       Date:  2014-11-26       Impact factor: 2.000

8.  Ox-LDL upregulates CRP expression through the IGF2 pathway in THP-1 macrophages.

Authors:  Shu-Fen Li; Yan-Wei Hu; Jia-Yi Zhao; Xin Ma; Shao-Guo Wu; Jing-Bo Lu; Ya-Rong Hu; Yan-Chao Wang; Ji-Juan Gao; Yan-Hua Sha; Lei Zheng; Qian Wang
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

9.  Pro-inflammatory cytokine polymorphisms in ONECUT2 and HNF4A and primary colorectal carcinoma: a post genome-wide gene-lifestyle interaction study.

Authors:  Su Yon Jung; Jeanette C Papp; Eric M Sobel; Matteo Pellegrini; Herbert Yu; Zuo-Feng Zhang
Journal:  Am J Cancer Res       Date:  2020-09-01       Impact factor: 6.166

10.  Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis.

Authors:  Yanmei Cheng; Aimin Dang; Naqiang Lv; Qian Gao; Bingwei Chen; Guozhang Liu
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.